TG Therapeutics | TGTX - EPS Earnings Per Share


TG Therapeutics reported $0.14 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.28 0.03 May/11
FY2025Q4 Dec/2025 0.14 0.33 0.15 Feb/26
FY2025Q3 Sep/2025 2.43 0.25 0.02 Nov/03
FY2025Q2 Jun/2025 0.17 0.20 0.04 Aug/04
FY2025Q1 Mar/2025 0.03 0.15 -0.07 May/05




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Alaunos Therapeutics USD -0.53 0.08 Sep/2025
Amgen USD 5.29 0.35 Dec/2025
Ardelyx USD 0 0 Dec/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
Bayer EUR 0.62 0.05 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
Corcept Therapeutics USD 0.2 0.04 Dec/2025
Curis USD 1.23 3.26 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
Infinity Pharmaceuticals USD -0.11 0.01 Jun/2023
J&J USD 2.46 0.34 Dec/2025
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
Novartis USD 1.54 0.5 Dec/2025
Novavax USD 0.13 0.59 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
TG Therapeutics USD 0.14 2.29 Dec/2025
Verastem USD -0.48 0.12 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025